Compare Stocks

EOG Resources, Inc., together with its subsidiaries, explores for, develops, produces, and markets crude oil, natural gas liquids, and natural gas primarily in producing basins in the United States, the Republic of Trinidad and Tobago and internationally. The company was formerly known as Enron Oil & Gas Company. EOG Resources, Inc. was incorporated in 1985 and is headquartered in Houston, Texas.

Pond Technologies Holdings Inc, formerly Ironhorse Oil & Gas Inc, is a Canada-based company that offers an algae growing platform, which converts carbon dioxide (CO2) into algal-based commercial products. As a pollution abatement technology, Pond Technologies Holdings Inc's algae growing platform converts the CO2 found in the untreated stack gas of industrial emitters into biofuels, animal feeds and natural fertilizers. For the Nutraceutical Market, Pond Technologies Holdings Inc's algae-growing platform transforms food-grade CO2 into algae strains such as Chlorella, Spirulina and Astaxanthin, all of which are used as health food additives and supplements. The Company partners with Saint Mary's Cement and the National Research Council of Canada to show that algae can be used to eliminate the greenhouse gas emissions from industrial facilities, transforming these emissions into bioproducts including biofuels, fertilizers, and animal feeds.

PEDEVCO Corp., an oil and gas company, focuses on the acquisition, development, and production of oil and natural gas assets in the United States. It holds interest in the Permian Basin asset with approximately 22,271 net acres located in New Mexico, the United States; and D-J Basin asset with approximately 19,214 net acres located in Wyoming, the United States. The company is headquartered in Houston, Texas.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Treasure Global Inc. offers e-commerce activities through its platform. Its platform provides consumers and merchants instant rebates and affiliate cashback programs, while providing a seamless e-payment solution with rebates in both e-commerce and physical retailers/merchant settings. The company offers ZCITY App, a payment gateway platform. Treasure Global Inc. was incorporated in 2020 and is based in New York, New York.